Chronic oral VP-16 for recurrent medulloblastoma

Pediatric Neurology

Volumn 17, Issue 3, 1997, Pages 230-234

  Chamberlain, Marc C ^a   Kormanik, Patty A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; LOMUSTINE; LOPERAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HUMAN; LONG TERM CARE; MALE; MEDULLOBLASTOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; ETOPOSIDE; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SALVAGE THERAPY; TIME FACTORS;

EID: 0030659029     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00098-2     Document Type: Article

References (38)

1. Packer RJ, Finlay JI. Medulloblastoma: Presentation, diagnosis and management. Oncology 1988;2:35-44.
2. Tomlinson FH, Scheithauer BW, Meyer FB, Smithson WA, Shaw EG, Miller GM, Groover RV. Medulloblastoma: I. clinical, diagnostic, and therapeutic overview. J Child Neurol 1992;7:142-55.
3. Duffner PK, Cohen ME, Myers MH, Heise HW. Survival of children with brain tumors: SEER program, 1973-1980. Neurology 1986;36:597-601.
4. Duffner P, Horowitz M, Krischer J, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-31.
5. Rutka JT, Hoffman HJ. Medulloblastoma: A historical perspective and overview. J Neuro-Oncol 1996;29:1-7.
6. Peterson K, Walker RW. Medulloblastoma/primitive neuroectodermal tumor in 45 adults. Neurology 1995;45:440-2.
7. Karoly MD, Casey ATH, Hayward RD, Harkness WFJ, Phipps K, Wase AM. Medulloblastoma: Is the 5-year survival rate improving? A review of 80 cases from a single institution. J Neurosurg 1997;86:13-21.
8. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson S, Mulne L, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81:690-8.
9. Lansky LL, List MA, Lansky SB, Cohen ME, Sinks LF. Toward the development of a play performance scale of children (PPSC). Cancer 1985;56:1837-40.
10. Packer RJ, Siegel KR, Sutton LN, Evans AE, D'Angio G, Rorke LB, Bunin GR, Schut L. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: A preliminary report. Ann Neurol 1988;24:503-8.
11. Packer RJ. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 1990;28:823-8.
12. Letkowitz IB, Packer RJ, Siegal KR, Sutton LN, Schut L, Evans AE. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin and vincristine. Cancer 1990;65:412-7.
13. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991; 74:433-40.
14. Lewis IJ, Stevens MCG, Pearson A, Pinkerton R, Stevens R. Phase II study of carboplatin in children's tumours. United Kingdom Children's Cancer Study Group, University of Leicester, UK (abstract). Proc Am Soc Clin Oncol 1993;12:121.
15. Kovnar E, Heideman R, Kellie S, Douglass E, Greenwald C, Kuttesch J, Ochs J, et al. Carboplatin and VP-16 in the treatment of high stage medulloblastoma, pineoblastoma and supratentorial PNET (abstract). Proc Am Soc Clin Oncol 1993;12:425.
16. Lewis IJ, Stevens MCG, Pearson A, Pinkerton CR, Stevens R. Phase II study of carboplatin in children's tumors (abstract). Proc Am Soc Clin Oncol 1993;12:412.
17. Ashley DM, Meier L, Kerby T, Zalduondo M, Friedman HS, Gajjar A, Kun L, et al. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol 1996;14:1922-7.
18. Chamberlain MC. Recurrent brainstem gliomas treated with oral VP-16. J Neuro-Oncol 1993;15:133-9.
19. Chamberlain MC. Recurrent supratentorial gliomas: Salvage therapy with oral etoposide (abstract). Ann Neurol 1996;40:335.
20. Chamberlain MC. Recurrent cerebellar gliomas: Salvage therapy with oral VP-16. Child Neurol 1997;12:200-4.
21. Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol 1995;13:2072-6.
22. Hainsworth JD, Greco FA. Etoposide: Twenty years later. Ann Oncol 1995;6:325-41.
23. Greco FA, Johnson DH, Hainsworth JD. Chronic oral etoposide. Cancer 1991;67:303-9.
24. MacDonald DR, Cascino TL, Schald SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80.
25. Levin VA, Edwards MSB, Gutin PH, Vestnys P, Fulton D, Seager M, Wilson CB. Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma. J Neurosurg 1984;61:1063-8.
26. Crafts DC, Levin VA, Edwards MS, Pischer TL, Wilson CB. Chemotherapy of recurrent medullo-blastoma with combined procarbazine, CCNU, and vincristine. J Neurosurg 1978;49:589-92.
27. Van Eys J, Baram TZ, Cangir A, Bruner JM, Martinez-Prieto J. Salvage chemotherapy for recurrent primary brain tumors in children. J Pediatr 1988;113:601-6.
28. Friedman HS, Schold SC Jr, Mahaley MS Jr, Calvin OM, Oakes WJ, Vick NA, Burger PC, et al. Phase II treatment of medulloblastoma and pineoblastoma with melphalan: Clinical therapy based on experimental models of human medulloblastoma. J Clin Oncol 1989;7: 904-11.
29. Baram TZ, Van Eys J, Dowell RE, Cangir A, Pack B, Bruner JM. Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. Cancer 1987;60: 173-7.
30. Allen JC, Helson L. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 1981;55:749-56.
31. Van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neuro-Oncol 1985;3:237-43.
32. Bertolone SJ, Baum ES, Krivit W, Hammond GD. A phase II study of cisplatin therapy in recurrent childhood brain tumors. J Neuro-Oncol 1989;7:5-11.
33. Walker RW, Allen JC. Treatment of recurrent primary intracranial childhood tumors with cis-diamminedichloroplatinum (abstract). Ann Neurol 1983;14:371-2.
34. Wara WM, Wallner KE, Levin VA, Liu H, Edwards MSB. Retreatment of pediatric brain tumors with radiation and misonidazole. Results of a CCSG/RTOG Phase I/II study. Cancer 1986;58:1636-40.
35. Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neuro-Oncol 1996;27:87-98.
36. Mahoney DH, Strother D, Camitta B, Bowen T, Ghim T, Pick T, Wall D, Yu L, Shuster JJ, Friedman H. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/ progressive malignant brain tumors in children: A pilot pediatric oncology group study. J Clin Oncol 1996;14:382-8.
37. Finlay JL, Goldman S, Wong MC, Cairo M, Garvin J, August C, Cohen BH, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 1996;14:2495-503.
38. Phillips PC, Carson BS, Calvin OM. Do topoisomerase inhibitors have a role in brain tumor chemotherapy? Detection of topoisomerase I and II in pediatric brain tumors (abstract). Ann Neurol 1990;28:218.